The Southern California Clinical and Translational Science Institute (SC-CTSI) has developed a freely available self-study module that can be used to train academic researchers in essential concepts and practical approaches to monitoring of clinical studies. The module addresses the need for quality management across the clinical trial lifecycle as stated in the latest addendum to ICH Guideline for Good Clinical Practice (GCP), E6(R2).
DIAMOND is a collaborative discovery learning space for clinical research professionals. Through the DIAMOND portal, you can access or share competency based training offerings and assessments for workforce development. DIAMOND also provides a unique e-Portfolio system powered by Portfolium.com so you can demonstrate and document your knowledge, skills, and abilities as well indentify areas for professional development.
Several challenges confront individuals who would like to pursue a research career, one of which being the escalating costs of advanced education and training in medicine and clinical specialties. This financial burden often leads scientists to abandon research careers for higher-paying private industry or private practice positions.
Posted: January 23, 2019
First Successful Use of a Patient-Derived Xenograft (PDX) Model to Guide Cancer Treatment
Mohamed Abazeed, MD, PhD became a CTSC KL2 Scholar in 2015. His research program focuses on identifying the genetic abnormalities that give rise to therapeutic resistance in cancer and using this information to develop personalized therapeutic strategies in a new strategy of biologically-guided treatments. He uses his experiences in patient care to develop a clinically relevant research program to study cancers and to translate laboratory discoveries into potential improvements in clinical care.
Cleveland Clinic Researcher Receives $2M Grant to Study Role of Cancer’s Genetic Composition in Predicting the Effectiveness of Radiation Therapy
Mohamed Abazeed, MD, PhD became a CTSC KL2 Scholar in 2015 under the mentorship of Michael Kattan, PhD and Jaroslaw Maciejewski, MD, PhD at the Cleveland Clinic. Dr. Abazeed's research program focuses on identifying the genetic abnormalities that give rise to therapeutic resistance in cancer and using this information to develop personalized therapeutic strategies in a new strategy of biologically-guided treatments.